series-b
Stage
2
Investors
About
Spur Therapeutics is a clinical-stage biotechnology company developing gene therapies aimed at treating debilitating chronic conditions. The company is focused on advancing clinical programs in gene therapy modalities for long-term disease management.
Explore Spur Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.